Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim Lammens

Showing results (61-70 of 77) with videos related to

Pageof 8
Sort By:
Leukemia|August 14, 2025
Underlying biology, challenges and emergent concepts in the treatment of relapsed and refractory pediatric T-cell acute lymphoblastic leukemiaPatrícia Amaral, Rhona Christie, Daisy O F Gresham, et al.
Blood|October 11, 2014
ABT-199 mediated inhibition of BCL-2 as a novel therapeutic strategy in T-cell acute lymphoblastic leukemiaSofie Peirs, Filip Matthijssens, Steven Goossens, et al.
Blood|October 17, 2014
The H3K27me3 demethylase UTX is a gender-specific tumor suppressor in T-cell acute lymphoblastic leukemiaJoni Van der Meulen, Viraj Sanghvi, Konstantinos Mavrakis, et al.
Blood|April 22, 2020
Targeting cytokine- and therapy-induced PIM1 activation in preclinical models of T-cell acute lymphoblastic leukemia and lymphomaRenate De Smedt, Julie Morscio, Lindy Reunes, et al.
Blood|December 30, 2015
LIN28B overexpression defines a novel fetal-like subgroup of juvenile myelomonocytic leukemiaHetty H Helsmoortel, Silvia Bresolin, Tim Lammens, et al.
Haematologica|November 9, 2023
Targeting hyperactive platelet-derived growth factor receptor-β signaling in T-cell acute lymphoblastic leukemia and lymphomaStien De Coninck, Renate De Smedt, Beatrice Lintermans, et al.
Haematologica|July 4, 2015
CD200/BTLA deletions in pediatric precursor B-cell acute lymphoblastic leukemia treated according to the EORTC-CLG 58951 protocolFarzaneh Ghazavi, Emmanuelle Clappier, Tim Lammens, et al.
Cancer Research|January 19, 2018
A Novel l-Asparaginase with low l-Glutaminase Coactivity Is Highly Efficacious against Both T- and B-cell Acute Lymphoblastic Leukemias <i>In Vivo</i>Hien Anh Nguyen, Ying Su, Jenny Y Zhang, et al.
European Journal of Cancer (Oxford, England : 1990)|November 19, 2021
The feasibility of using liquid biopsies as a complementary assay for copy number aberration profiling in routinely collected paediatric cancer patient samplesRuben Van Paemel, Charlotte Vandeputte, Lennart Raman, et al.
JCI Insight|December 7, 2018
Circulating microRNA biomarkers for metastatic disease in neuroblastoma patientsFjoralba Zeka, Anneleen Decock, Alan Van Goethem, et al.
Pageof 8

Showing results (61-70 of 77) with videos related to

Sort By:
Pageof 8
Leukemia|August 14, 2025
Underlying biology, challenges and emergent concepts in the treatment of relapsed and refractory pediatric T-cell acute lymphoblastic leukemiaPatrícia Amaral, Rhona Christie, Daisy O F Gresham, et al.
Blood|October 11, 2014
ABT-199 mediated inhibition of BCL-2 as a novel therapeutic strategy in T-cell acute lymphoblastic leukemiaSofie Peirs, Filip Matthijssens, Steven Goossens, et al.
Blood|October 17, 2014
The H3K27me3 demethylase UTX is a gender-specific tumor suppressor in T-cell acute lymphoblastic leukemiaJoni Van der Meulen, Viraj Sanghvi, Konstantinos Mavrakis, et al.
Blood|April 22, 2020
Targeting cytokine- and therapy-induced PIM1 activation in preclinical models of T-cell acute lymphoblastic leukemia and lymphomaRenate De Smedt, Julie Morscio, Lindy Reunes, et al.
Blood|December 30, 2015
LIN28B overexpression defines a novel fetal-like subgroup of juvenile myelomonocytic leukemiaHetty H Helsmoortel, Silvia Bresolin, Tim Lammens, et al.
Haematologica|November 9, 2023
Targeting hyperactive platelet-derived growth factor receptor-β signaling in T-cell acute lymphoblastic leukemia and lymphomaStien De Coninck, Renate De Smedt, Beatrice Lintermans, et al.
Haematologica|July 4, 2015
CD200/BTLA deletions in pediatric precursor B-cell acute lymphoblastic leukemia treated according to the EORTC-CLG 58951 protocolFarzaneh Ghazavi, Emmanuelle Clappier, Tim Lammens, et al.
Cancer Research|January 19, 2018
A Novel l-Asparaginase with low l-Glutaminase Coactivity Is Highly Efficacious against Both T- and B-cell Acute Lymphoblastic Leukemias <i>In Vivo</i>Hien Anh Nguyen, Ying Su, Jenny Y Zhang, et al.
European Journal of Cancer (Oxford, England : 1990)|November 19, 2021
The feasibility of using liquid biopsies as a complementary assay for copy number aberration profiling in routinely collected paediatric cancer patient samplesRuben Van Paemel, Charlotte Vandeputte, Lennart Raman, et al.
JCI Insight|December 7, 2018
Circulating microRNA biomarkers for metastatic disease in neuroblastoma patientsFjoralba Zeka, Anneleen Decock, Alan Van Goethem, et al.
Pageof 8